Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
the majority of the low trades are only a few hundred shares each. Just seems a little odd to me that we see so many trades of a few quid each dragging the sp back..
for what its worth the share price is not being held back by small trades, as you say these are insignificant. It is where it is because there is no news or figures to take it further....simple as.
Threeskins,
I agree these trades today are nothing and numbers are required. They are on the way though, so not long to wait now :
CooperD,
I hope so, although my naturally pessimistic nature coupled with experience from previous and current investments makes me think that most of the potentially good news will already be incorporated into the sp value. I think any changes north will be down to absolute trading values and potential new market exposure. Changes south will be far greater than the upside if some of the eagerly anticipated approvals don't happen. From someone who is invested in AMARIN I've learnt never to take anything for granted.
Threeskins; by 'approval' do you mean the pending Illumina CE mark and soon to be launched Clarigene? If so, I think we can all rest easy where that's concerned! Not sure if there is anything else you mean.
I have no doubt regarding approvals. They aren't approved till we are told they have been received but it's as good as done imo. As far as the future growth well that all opens up on the CE mark being awarded. More than confident here.
Hi Bakky,
Sorry, yes I meant exactly that. I think it underpins everything, but it will be nice to hear it officially rather than speculate. I have followed this thread for the last 6 months and there are many people on here far more knowledgeable than myself on YGEN and they seem confident so I am not overly worried. Coming from a background of 30yrs plus in Biotech/drug discovery I just know not to count the proverbial chickens. Incidentally, like a few others on here I think the Covid saga is a nice side show that hopefully brings in decent revenue, but there are many players now and the guys that got in early made the killings. My inbox is spammed with companies offering Covid testing kits/reagents etc you just have to be seen wearing the trousers.